A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Extending and validating the Baveno VI criteria for the exclusion of high-risk varices
2021
Medical ultrasonography
The updated Baveno VI guidelines recommend that screening for high-risk varices (HRV) by esophago-gastro-duodenoscopy (EGD) can be avoided in patients with compensated advanced chronic liver disease (cACLD) who have liver stiffness LSM<20 kPa and platelet count PLT>150,000/L. The aims of this study were to validate extended Baveno VI criteria in patients with chronic liver disease and to establish cut-off values for our cohort. This retrospective study included 839 patients with liver cirrhosis
doi:10.11152/mu-2929
pmid:33657192
fatcat:gkgwq4h7obhjzfemzcmfilu47u